If You Want to Get Something Done, Hire a Cancer Patient

Why It Matters

Retaining cancer‑affected employees reduces turnover costs and strengthens DEI initiatives, turning a perceived liability into a competitive advantage.

Key Takeaways

• 60% of US cancer patients aged 25‑62 work during treatment
• 18.6 million cancer survivors projected in US by 2025
• Remote work enables patients to maintain productivity despite treatment side effects
• Employers gain resilient employees with heightened grit and problem‑solving skills
• Flexible policies reduce turnover and improve DEI metrics for organizations

Pulse Analysis

The United States will host roughly 18.6 million cancer survivors by 2025, and a recent Cancer journal study shows that about 60 percent of patients between 25 and 62 remain employed while undergoing treatment. This marks a stark departure from the long‑standing belief that a diagnosis automatically sidelines workers. Advances in targeted therapies, immunotherapy, and CAR‑T cell treatment have turned many cancers into chronic conditions rather than terminal events, allowing patients to sustain regular schedules, especially when remote‑work tools are available.

Employers who retain cancer‑affected staff discover a hidden asset: grit forged through repeated cycles of treatment, hospital visits, and recovery. The author, a journalist who has navigated multiple rounds of radiation, immunotherapy and CAR‑T while meeting editorial deadlines, illustrates how chronic illness can sharpen focus, time‑management, and problem‑solving abilities. Remote‑friendly arrangements—working from a clinic, home or even a hospital bed—enable continuity of output, while the psychological benefit of purposeful work helps mitigate anxiety and depression often associated with a life‑threatening diagnosis.

From a business standpoint, flexible accommodations translate into lower turnover, higher employee engagement, and stronger diversity, equity and inclusion (DEI) scores. Simple measures—adjusted schedules, telecommuting options, and private spaces for infusion therapy—cost far less than recruiting and training replacements. Moreover, showcasing support for employees battling serious illness enhances corporate reputation, attracting talent that values empathy and resilience. As the survivor population ages, forward‑looking firms that embed health‑centric policies will capture a competitive edge while contributing to a more inclusive, productive workforce.